| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7503024 | Drug and Alcohol Dependence | 2018 | 7 Pages |
Abstract
Chronic dronabinol dosing can reduce cannabis self-administration in daily cannabis users and suppress withdrawal symptoms. Cannabinoid agonist medications should continue to be explored for therapeutic utility in the treatment of cannabis use disorders.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Nicolas J. Schlienz, Dustin C. Lee, Maxine L. Stitzer, Ryan Vandrey,